PARP4 and MVP

  • Number of citations of the paper that reports this interaction (PMID 10477748)
  • 55
  • Data Source:
  • BioGRID (two hybrid, two hybrid, pull down)
  • HPRD (two hybrid, in vitro, in vivo)

PARP4

MVP

Gene Name poly (ADP-ribose) polymerase family, member 4 major vault protein
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 2 interactors: MVP SMAD3 57 interactors: ADAMTSL4 AES BANP BZRAP1 C1orf94 CALCOCO2 CAMK2B CCDC36 CKAP4 CYTB DISC1 DLX2 EPHX2 ESR1 FAM154A FAM46C GIT2 GOLGA2 HP KCTD9 KPNA2 KPNA3 MDFI MEOX1 MEOX2 MID2 MKL1 NNT NOTCH2NL OBFC1 PARP4 PIH1D2 PLSCR1 POT1 PSTPIP1 PTEN PTPN11 RAB3IP RBPMS REL RHOXF2 RIMBP3 RNF111 SERTAD1 SKIL SLC2A4 TCF4 TFCP2 TP53 TRAF2 TRIM27 TRIM42 TRIP13 TRIP6 VAC14 ZBTB32 ZMIZ2
Entrez ID 143 9961
HPRD ID 09598 05475
Ensembl ID ENSG00000102699 ENSG00000013364
Uniprot IDs Q9UKK3 B4DP93 Q14764
PDB IDs 1Y7X
Enriched GO Terms of Interacting Partners?
Tagcloud ?
afp  bleomycin  bronchogenic  cap  chance  cisplatin  cooperative  crs  cyclophosphamide  doxorubicin  eastern  ecog  efficacious  entered  est  evaluable  fluorouracil  institution  lethal  mitomycin  modest  nscbc  october  oncology  prs  regimens  shrinkage  threatening  vinblastine 
Tagcloud (Difference) ?
afp  bleomycin  bronchogenic  cap  chance  cisplatin  cooperative  crs  cyclophosphamide  doxorubicin  eastern  ecog  efficacious  entered  est  evaluable  fluorouracil  institution  lethal  mitomycin  modest  nscbc  october  oncology  prs  regimens  shrinkage  threatening  vinblastine 
Tagcloud (Intersection) ?